n(g),n(g')-dimethyl-l-arginine has been researched along with Brain Ischemia in 12 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Brain Ischemia: Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Increased levels of asymmetric dimethylarginine (ADMA) have been observed in patients with acute ischemic stroke." | 9.19 | Supplementation of folic acid and vitamin B₁₂ reduces plasma levels of asymmetric dimethylarginine in patients with acute ischemic stroke. ( Li, X; Ma, JP; Wang, JZ; Wang, L; Wu, CJ; Xia, XS, 2014) |
| "The aim of this study was to evaluate serum ADMA levels, which are an indicator of endothelial dysfunction of the renal functions in patients with acute ischemic stroke, and to determine whether there is a possible correlation between ADMA and NO levels and the l-arginine-to-ADMA ratio." | 7.91 | Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke. ( Abusoglu, S; Akbulut, D; Bal, C; Celik, HT; Ercan, M; Güzel, I; Mungan, S; Oguz, EF; Yilmaz, FM, 2019) |
| "To determine the role of asymmetric dimethylarginine (ADMA) in acute lung injury induced by cerebral ischemia/reperfusion (I/R) injury in rats." | 7.77 | Role of asymmetric dimethylarginine in acute lung injury induced by cerebral ischemia/reperfusion injury in rats. ( Wang, DH; Wu, YH; Zhang, X, 2011) |
| "We hypothesise that asymmetric and symmetric dimethylarginine (ADMA, SDMA) are released in cerebrospinal fluid (CSF) due to ischemia-induced proteolysis and that CSF dimethylarginines are related to stroke severity." | 7.75 | Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity. ( Brouns, R; De Deyn, PP; Marescau, B; Possemiers, I; Sheorajpanday, R, 2009) |
| "Delayed cerebral ischemia (DCI) is the major cause of lethality and neuronal damage in patients who survived the primary subarachnoid hemorrhage (SAH)." | 5.48 | Asymmetric and Symmetric Dimethylarginines are Markers of Delayed Cerebral Ischemia and Neurological Outcome in Patients with Subarachnoid Hemorrhage. ( Appel, D; Böger, RH; Czorlich, P; Goetz, AE; Hannemann, J; Schwedhelm, E; Seeberger, M, 2018) |
| "Increased levels of asymmetric dimethylarginine (ADMA) have been observed in patients with acute ischemic stroke." | 5.19 | Supplementation of folic acid and vitamin B₁₂ reduces plasma levels of asymmetric dimethylarginine in patients with acute ischemic stroke. ( Li, X; Ma, JP; Wang, JZ; Wang, L; Wu, CJ; Xia, XS, 2014) |
| "The aim of this study was to evaluate serum ADMA levels, which are an indicator of endothelial dysfunction of the renal functions in patients with acute ischemic stroke, and to determine whether there is a possible correlation between ADMA and NO levels and the l-arginine-to-ADMA ratio." | 3.91 | Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke. ( Abusoglu, S; Akbulut, D; Bal, C; Celik, HT; Ercan, M; Güzel, I; Mungan, S; Oguz, EF; Yilmaz, FM, 2019) |
| "Guanidino compounds, including l-homoarginine (l-hArg), symmetric dimethylarginine (SDMA), asymmetric dimethylarginine (ADMA) and l-arginine (l-Arg) are associated with mortality, fatal strokes, stroke incidence, and atherosclerosis." | 3.91 | Guanidino compound ratios are associated with stroke etiology, internal carotid artery stenosis and CHA ( Atzler, D; Böger, RH; Choe, CU; Cordts, K; Gerloff, C; Grant, PJ; Grzybowski, R; Hornig, S; Lezius, S; Lüneburg, N; Magnus, T; Neu, A; Schwedhelm, E; Thomalla, G, 2019) |
| "To determine the role of asymmetric dimethylarginine (ADMA) in acute lung injury induced by cerebral ischemia/reperfusion (I/R) injury in rats." | 3.77 | Role of asymmetric dimethylarginine in acute lung injury induced by cerebral ischemia/reperfusion injury in rats. ( Wang, DH; Wu, YH; Zhang, X, 2011) |
| "We hypothesise that asymmetric and symmetric dimethylarginine (ADMA, SDMA) are released in cerebrospinal fluid (CSF) due to ischemia-induced proteolysis and that CSF dimethylarginines are related to stroke severity." | 3.75 | Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity. ( Brouns, R; De Deyn, PP; Marescau, B; Possemiers, I; Sheorajpanday, R, 2009) |
| "Delayed cerebral ischemia (DCI) is the major cause of lethality and neuronal damage in patients who survived the primary subarachnoid hemorrhage (SAH)." | 1.48 | Asymmetric and Symmetric Dimethylarginines are Markers of Delayed Cerebral Ischemia and Neurological Outcome in Patients with Subarachnoid Hemorrhage. ( Appel, D; Böger, RH; Czorlich, P; Goetz, AE; Hannemann, J; Schwedhelm, E; Seeberger, M, 2018) |
| "After aneurysmal subarachnoid hemorrhage (SAH) disturbance of this equilibrium may evoke delayed cerebral vasospasm (CVS) leading to delayed cerebral ischemia (DCI)." | 1.38 | The CSF concentration of ADMA, but not of ET-1, is correlated with the occurrence and severity of cerebral vasospasm after subarachnoid hemorrhage. ( Jung, CS; Lange, B; Seifert, V; Zimmermann, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 11 (91.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appel, D | 1 |
| Seeberger, M | 1 |
| Schwedhelm, E | 3 |
| Czorlich, P | 1 |
| Goetz, AE | 1 |
| Böger, RH | 3 |
| Hannemann, J | 1 |
| Ercan, M | 1 |
| Mungan, S | 1 |
| Güzel, I | 1 |
| Celik, HT | 1 |
| Bal, C | 1 |
| Abusoglu, S | 1 |
| Akbulut, D | 1 |
| Oguz, EF | 1 |
| Yilmaz, FM | 1 |
| Cordts, K | 1 |
| Grzybowski, R | 1 |
| Lezius, S | 1 |
| Lüneburg, N | 2 |
| Atzler, D | 1 |
| Neu, A | 1 |
| Hornig, S | 1 |
| Gerloff, C | 1 |
| Magnus, T | 1 |
| Thomalla, G | 1 |
| Grant, PJ | 1 |
| Choe, CU | 1 |
| Chen, S | 1 |
| Li, N | 1 |
| Deb-Chatterji, M | 1 |
| Dong, Q | 1 |
| Kielstein, JT | 1 |
| Weissenborn, K | 1 |
| Worthmann, H | 1 |
| Xia, XS | 1 |
| Li, X | 1 |
| Wang, L | 1 |
| Wang, JZ | 1 |
| Ma, JP | 1 |
| Wu, CJ | 1 |
| Brouns, R | 1 |
| Marescau, B | 1 |
| Possemiers, I | 1 |
| Sheorajpanday, R | 1 |
| De Deyn, PP | 1 |
| Nishiyama, Y | 2 |
| Ueda, M | 2 |
| Katsura, K | 2 |
| Otsuka, T | 2 |
| Abe, A | 2 |
| Nagayama, H | 2 |
| Katayama, Y | 2 |
| Mamatha, SN | 1 |
| Nagaraja, D | 1 |
| Philip, M | 1 |
| Christopher, R | 1 |
| von Holten, RA | 1 |
| Töpper, RF | 1 |
| Maas, R | 1 |
| Wu, YH | 1 |
| Zhang, X | 1 |
| Wang, DH | 1 |
| Jung, CS | 1 |
| Lange, B | 1 |
| Zimmermann, M | 1 |
| Seifert, V | 1 |
1 review available for n(g),n(g')-dimethyl-l-arginine and Brain Ischemia
| Article | Year |
|---|---|
Asymmetric dimethyarginine as marker and mediator in ischemic stroke.
Topics: Animals; Arginine; Biomarkers; Brain Ischemia; Cerebrovascular Circulation; Enzyme Inhibitors; Human | 2012 |
2 trials available for n(g),n(g')-dimethyl-l-arginine and Brain Ischemia
| Article | Year |
|---|---|
Supplementation of folic acid and vitamin B₁₂ reduces plasma levels of asymmetric dimethylarginine in patients with acute ischemic stroke.
Topics: Aged; Arginine; Blood Chemical Analysis; Brain Ischemia; Dietary Supplements; Female; Folic Acid; Fo | 2014 |
Statin treatment decreased serum asymmetric dimethylarginine (ADMA) levels in ischemic stroke patients.
Topics: Aged; Aged, 80 and over; Arginine; Atherosclerosis; Atorvastatin; Brain Ischemia; Cholesterol, LDL; | 2011 |
9 other studies available for n(g),n(g')-dimethyl-l-arginine and Brain Ischemia
| Article | Year |
|---|---|
Asymmetric and Symmetric Dimethylarginines are Markers of Delayed Cerebral Ischemia and Neurological Outcome in Patients with Subarachnoid Hemorrhage.
Topics: Adult; Aged; Arginine; Biomarkers; Brain Ischemia; Cerebral Angiography; Female; Humans; Incidence; | 2018 |
Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke.
Topics: Aged; Aged, 80 and over; Arginine; Brain Ischemia; Female; Humans; Male; Middle Aged; Nitric Oxide; | 2019 |
Guanidino compound ratios are associated with stroke etiology, internal carotid artery stenosis and CHA
Topics: Aged; Arginine; Biomarkers; Brain Ischemia; Carotid Arteries; Carotid Stenosis; Cross-Sectional Stud | 2019 |
Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity.
Topics: Aged; Arginine; Brain Ischemia; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Strok | 2009 |
Asymmetric dimethylarginine (ADMA) as a possible risk marker for ischemic stroke.
Topics: Age Factors; Aged; Arginine; Biomarkers; Blood Glucose; Brain Ischemia; Cholesterol, LDL; Dyslipidem | 2010 |
Asymmetric dimethylarginine as a risk marker for early-onset ischemic stroke in Indian population.
Topics: Adolescent; Adult; Analysis of Variance; Arginine; Biomarkers; Brain Ischemia; Case-Control Studies; | 2011 |
Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Brain Ischemia; Chromatography, Liquid; Female; Follo | 2012 |
Role of asymmetric dimethylarginine in acute lung injury induced by cerebral ischemia/reperfusion injury in rats.
Topics: Acute Lung Injury; Animals; Arginine; Brain Ischemia; Male; Myosin-Light-Chain Kinase; Nitric Oxide | 2011 |
The CSF concentration of ADMA, but not of ET-1, is correlated with the occurrence and severity of cerebral vasospasm after subarachnoid hemorrhage.
Topics: Adult; Arginine; Brain Ischemia; Endothelin-1; Female; Humans; Male; Middle Aged; Nitric Oxide; Retr | 2012 |